Fetal Brain mTOR Signaling Activation in Tuberous Sclerosis Complex
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Tuberous sclerosis complex (TSC) is characterized by developmental malformations of the cerebral cortex known as tubers, comprised of cells that exhibit enhanced mammalian target of rapamycin (mTOR) signaling. To date, there are no reports of mTORC1 and mTORC2 activation in fetal tubers or in neural progenitor cells lacking Tsc2. We demonstrate mTORC1 activation by immunohistochemical detection of substrates phospho-p70S6K1 (T389) and phospho-S6 (S235/236), and mTORC2 activation by substrates phospho-PKCα (S657), phospho-Akt (Ser473), and phospho-SGK1 (S422) in fetal tubers. Then, we show that Tsc2 shRNA knockdown (KD) in mouse neural progenitor cells (mNPCs) in vitro results in enhanced mTORC1 (phospho-S6, phospho-4E-BP1) and mTORC2 (phospho-Akt and phospho-NDRG1) signaling, as well as a doubling of cell size that is rescued by rapamycin, an mTORC1 inhibitor. Tsc2 KD in vivo in the fetal mouse brain by in utero electroporation causes disorganized cortical lamination and increased cell volume that is prevented with rapamycin. We demonstrate for the first time that mTORC1 and mTORC2 signaling is activated in fetal tubers and in mNPCs following Tsc2 KD. These results suggest that inhibition of mTOR pathway signaling during embryogenesis could prevent abnormal brain development in TSC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Self-citationThe TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093
García-Martínez, J. M., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20081668 · Cited by 907
Tbr1 regulates differentiation of the preplate and layer 6
Hevner, R. F., Shi, L., Justice, N., Hsueh, Y.-P., Sheng, M., Smiga, S., Bulfone, A., Goffinet, A. M., Campagnoni, A. T., & Rubenstein, J. L. R. (2001) · Neuron · doi:10.1016/s0896-6273(01)00211-2 · Cited by 857
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
Zeng, L., Xu, L., Gutmann, D. H., & Wong, M. (2008) · Annals of Neurology · doi:10.1002/ana.21331 · Cited by 639 · cited 1×
“Similarly, postnatal treatment with rapamycin in both Tsc1Cre (Zeng et al. 2008) and Tsc2Cre (Zeng et al.”
BackgroundMeikle, L., Talos, D. M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen, F. E., & Kwiatkowski, D. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5540-06.2007 · Cited by 462
Uhlmann, E. J., Wong, M., Baldwin, R. L., Bajenaru, M. L., Onda, H., Kwiatkowski, D. J., Yamada, K., & Gutmann, D. H. (2002) · Annals of Neurology · doi:10.1002/ana.10283 · Cited by 372
Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin
Carson, R. P., Van Nielen, D. L., Winzenburger, P. A., & Ess, K. C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.024 · Cited by 165
Research works printed but not linked: 44
- Anderl, 2011, Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex, Hum Mol Genet, 20, 4597, 10.1093/hmg/ddr393 · DOI · Paper page
- Arlotta, 2005, Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo, Neuron, 45, 207, 10.1016/j.neuron.2004.12.036 · DOI · Paper page
- Bai, 2003, RNAi reveals doublecortin is required for radial migration in rat neocortex, Nat Neurosci, 6, 1277, 10.1038/nn1153 · DOI · Paper page
- Bissler, 2008, Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis, N Engl J Med, 358, 140, 10.1056/NEJMoa063564 · DOI · Paper page
- Chen, 2005, Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex, Proc Natl Acad Sci USA, 102, 17184, 10.1073/pnas.0508732102 · DOI · Paper page
- Chen, 2010, Prenatal diagnosis of rhabdomyomas and cerebral tuberous sclerosis by magnetic resonance imaging in one fetus of a dizygotic twin pregnancy associated with a frameshift mutation in the TSC2 gene, Taiwan J Obstet Gynecol, 49, 387, 10.1016/S1028-4559(10)60083-6 · doi:10.1016/s1028-4559(10)60083-6
- Crino, 2010, The pathophysiology of tuberous sclerosis complex, Epilepsia, 51, 27, 10.1111/j.1528-1167.2009.02438.x · DOI
- Cubelos, 2010, Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex, Neuron, 66, 523, 10.1016/j.neuron.2010.04.038 · DOI · Paper page
- DiMario, 2004, Brain abnormalities in tuberous sclerosis complex, J Child Neurol, 19, 650, 10.1177/08830738040190090401 · DOI · Paper page
- Ess, 2012, New therapies for tuber-less sclerosis: white matter matters?, Neurology, 78, 520, 10.1212/WNL.0b013e318248a232 · DOI
- Feliciano, 2011, Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice, J Clin Invest, 121, 1596, 10.1172/JCI44909 · DOI · Paper page
- Goto, 2011, Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex, Proc Natl Acad Sci USA, 108, E1070, 10.1073/pnas.1106454108 · DOI · Paper page
- Huang, 2008, The TSC1-TSC2 complex is required for proper activation of mTOR complex 2, Mol Cell Biol, 28, 4104, 10.1128/MCB.00289-08 · DOI · Paper page
- Huang, 2009, Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors, Cancer Res, 69, 6107, 10.1158/0008-5472.CAN-09-0975 · DOI · Paper page
- Jambaque, 1991, Neuropsychological aspects of tuberous sclerosis in relation to epilepsy and MRI findings, Dev Med Child Neurol, 33, 698, 10.1111/j.1469-8749.1991.tb14947.x · DOI · Paper page
- Krueger, 2010, Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis, N Engl J Med, 363, 1801, 10.1056/NEJMoa1001671 · DOI · Paper page
- Kwon, 2003, mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo, Proc Natl Acad Sci USA, 100, 12923, 10.1073/pnas.2132711100 · DOI · Paper page
- Kyin, 2001, Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex, Am J Pathol, 159, 1541, 10.1016/S0002-9440(10)62539-4 · DOI
- Levine, 1999, Central nervous system abnormalities assessed with prenatal magnetic resonance imaging, Obstet Gynecol, 94, 1011
- Magnitsky, 2008, Magnetic resonance imaging detects differences in migration between primary and immortalized neural stem cells, Acad Radiol, 15, 1269, 10.1016/j.acra.2008.05.003 · DOI
- Marcotte, 2012, Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex, Acta Neuropathol, 123, 685, 10.1007/s00401-012-0950-3 · DOI
- Marcotte, 2006, The neurobiology of the tuberous sclerosis complex, Neuromol Med, 8, 531, 10.1385/NMM:8:4:531 · DOI
- Meikle, 2008, Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function, J Neurosci, 28, 5422, 10.1523/JNEUROSCI.0955-08.2008 · DOI · Paper page
- Molyneaux, 2005, Fezl is required for the birth and specification of corticospinal motor neurons, Neuron, 47, 817, 10.1016/j.neuron.2005.08.030 · DOI · Paper page
- Nguyen, 2006, p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex, Genes Dev, 20, 1511, 10.1101/gad.377106 · DOI · Paper page
- Nieto, 2004, Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex, J Comp Neurol, 479, 168, 10.1002/cne.20322 · DOI · Paper page
- Orlova, 2010, STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice, J Clin Invest, 120, 1591, 10.1172/JCI41592 · DOI · Paper page
- Orlova, 2010, Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias, J Neuropathol Exp Neurol, 69, 850, 10.1097/NEN.0b013e3181eac1f5 · DOI · Paper page
- Park, 1997, Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study, Acta Neuropathol, 94, 180, 10.1007/s004010050691 · DOI
- Parker, 2011, Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex, Am J Pathol, 178, 296, 10.1016/j.ajpath.2010.11.031 · DOI
- Ruegg, 2007, Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons, Epilepsy Res, 77, 85, 10.1016/j.eplepsyres.2007.09.009 · DOI
- Saito, 2006, In vivo electroporation in the embryonic mouse central nervous system, Nat Protoc, 1, 1552, 10.1038/nprot.2006.276 · DOI · Paper page
- Samuel-Abraham, 2010, Staying on message: design principles for controlling nonspecific responses to siRNA, FEBS J, 277, 4828, 10.1111/j.1742-4658.2010.07905.x · DOI
- Sparagana, 2000, Tuberous sclerosis complex, Curr Opin Neurol, 13, 115, 10.1097/00019052-200004000-00001 · DOI · Paper page
- Tanaka, 2011, Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance, Cancer Discov, 1, 524, 10.1158/2159-8290.CD-11-0124 · DOI · Paper page
- Tillema, 2012, Everolimus alters white matter diffusion in tuberous sclerosis complex, Neurology, 78, 526, 10.1212/WNL.0b013e318247ca8d · DOI · Paper page
- Wang, 2007, Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1, Ann Neurol, 61, 139, 10.1002/ana.21058 · DOI · Paper page
- Way, 2009, Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse, Hum Mol Genet, 18, 1252, 10.1093/hmg/ddp025 · DOI · Paper page
- Way, 2012, The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex, Hum Mol Genet, 21, 3226, 10.1093/hmg/dds156 · DOI · Paper page
- Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471, 10.1016/j.cell.2006.01.016 · DOI · Paper page
- Yang, 2006, TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity, Proc Natl Acad Sci USA, 103, 6811, 10.1073/pnas.0602282103 · DOI · Paper page
- Zaroff, 2006, Mental retardation and relation to seizure and tuber burden in tuberous sclerosis complex, Seizure, 15, 558, 10.1016/j.seizure.2006.06.010 · DOI
- Zeng, 2010, Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?, Cell Cycle., 9, 2281, 10.4161/cc.9.12.11866 · DOI
- Zeng, 2011, Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex, Hum Mol Genet, 20, 445, 10.1093/hmg/ddq491 · DOI · Paper page
Cited by
Henske, E. P., Jóźwiak, S., Kingswood, J. C., Sampson, J. R., & Thiele, E. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.35 · Cited by 831
The mTOR signalling cascade: paving new roads to cure neurological disease
Crino, P. B. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.81 · Cited by 368
Self-citationmTOR signaling and its roles in normal and abnormal brain development
Takei, N., & Nawa, H. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00028 · Cited by 317
“Although the direct interaction of TSC1/2 and mTORC2 is still unclear, phosphorylation of mTORC2 substrates PKCa at Ser657, Akt at Ser473, and SGK1 at Ser422 have also been observed in the fetal TSC brain (Tsai et al., 2012).”
BackgroundmTORC2 controls actin polymerization required for consolidation of long-term memory
Huang, W., Zhu, P. J., Zhang, S., Zhou, H., Stoica, L., Galiano, M., Krnjević, K., Roman, G., & Costa-Mattioli, M. (2013) · Nature Neuroscience · doi:10.1038/nn.3351 · Cited by 307
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex
Salussolia, C. L., Klonowska, K., Kwiatkowski, D. J., & Sahin, M. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083118-015354 · Cited by 163
Mühlebner, A., van Scheppingen, J., Hulshof, H. M., Scholl, T., Iyer, A. M., Anink, J. J., van den Ouweland, A. M. W., Nellist, M. D., Jansen, F. E., Spliet, W. G. M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157396 · Cited by 88
Self-citationGATOR1 complex: the common genetic actor in focal epilepsies
Baldassari, S., Licchetta, L., Tinuper, P., Bisulli, F., & Pippucci, T. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103883 · Cited by 80
Sarnat, H. B., & Flores-Sarnat, L. (2015) · Brain and Development · doi:10.1016/j.braindev.2014.08.010 · Cited by 73
Self-citationThe Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC)
Feliciano, D. M. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.00039 · Cited by 69
“There are few examples of detailed analysis of TSC fetal tissue in the scientific literature (Park et al., 1997; Prabowo et al., 2013; Parker et al., 2014).”
BackgroundRegulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1
Lang, F., Stournaras, C., & Alesutan, I. (2014) · Molecular Membrane Biology · doi:10.3109/09687688.2013.874598 · Cited by 66
Metadata
- Authors
- Tsai, V., Parker, W. E., Orlova, K. A., Baybis, M., Chi, A. W. S., Berg, B. D., Birnbaum, J. F., Estevez, J., Okochi, K., Sarnat, H. B., Flores-Sarnat, L., Aronica, E., & Crino, P. B.
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10-18
- Volume
- 24
- Issue
- 2
- Pages
- 315-327
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2169878097
- Cited by
- 116
- References
- 10
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.